Business Context and Reporting Period
This Form 8-K reports on the 2012 Annual Meeting of Stockholders for Oculus Innovative Sciences, Inc., held on September 11, 2012. The filing details the voting results for director elections and the ratification of the independent auditor. Note: The request metadata references "Sonoma Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as Oculus Innovative Sciences, Inc.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
No material financial changes are reported in this filing. The document focuses solely on the outcomes of shareholder votes.
Guidance, Outlook, and Management Commentary
The filing contains no management guidance, outlook, risk factors, or discussion of unusual items. It strictly reports the final voting results for two proposals:
- Proposal 1 (Election of Directors): Hojabr Alimi and Jim Schutz were elected as Class I directors.
- Proposal 2 (Auditor Ratification): The appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2013, was ratified.
Important Facts for Investor Verification
- Shareholder Participation: Of 32,553,662 shares entitled to vote, 21,894,560 shares were present or represented by proxy (approximately 67.2% participation).
- Director Election Results:
- Hojabr Alimi: 4,797,431 votes FOR; 563,099 votes WITHHELD.
- Jim Schutz: 4,787,041 votes FOR; 573,489 votes WITHHELD.
- Auditor Ratification Results: 20,388,794 votes FOR; 1,247,560 votes AGAINST; 258,206 votes ABSTAIN.
- Company Identity: Verify that the investment thesis aligns with Oculus Innovative Sciences, Inc., not Sonoma Pharmaceuticals, Inc., as the filing text confirms the former.